EMEA-000145-PIP02-12-M01

Key facts

Invented name
  • Prolia
  • Xgeva
Active substance
denosumab
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0058/2016
PIP number
EMEA-000145-PIP02-12-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of osteoporosis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Amgen Europe B.V.
United Kingdom
Tel. +44 (0)1223 420305
E-mail: pipenquiry@amgen.com

 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating